These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8735837)

  • 1. Role of lipoproteins in platelet activation.
    Zhao B
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):270-3. PubMed ID: 8735837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.
    Takahashi Y; Chiba H; Matsuno K; Akita H; Hui SP; Nagasaka H; Nakamura H; Kobayashi K; Tandon NN; Jamieson GA
    Biochem Biophys Res Commun; 1996 May; 222(2):453-9. PubMed ID: 8670226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
    Blache D; Gautier T; Tietge UJ; Lagrost L
    FASEB J; 2012 Feb; 26(2):927-37. PubMed ID: 22042222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.
    Dardik R; Varon D; Tamarin I; Zivelin A; Salomon O; Shenkman B; Savion N
    Thromb Haemost; 2000 Feb; 83(2):338-44. PubMed ID: 10739396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective role of high-density lipoprotein on oxidized-low-density-lipoprotein-induced U937/endothelial cell interactions.
    Maier JA; Barenghi L; Pagani F; Bradamante S; Comi P; Ragnotti G
    Eur J Biochem; 1994 Apr; 221(1):35-41. PubMed ID: 7513283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein as a modulator of platelet and coagulation responses.
    van der Stoep M; Korporaal SJ; Van Eck M
    Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y
    Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein.
    Galle J; Ochslen M; Schollmeyer P; Wanner C
    Hypertension; 1994 May; 23(5):556-64. PubMed ID: 8175161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipoproteins on cultured human mesangial cells.
    Nishida Y; Yorioka N; Oda H; Yamakido M
    Am J Kidney Dis; 1997 Jun; 29(6):919-30. PubMed ID: 9186079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous L-arginine and HDL can alter LDL and ox-LDL-mediated platelet activation: using platelet P-selectin receptor numbers.
    Sener A; Enc E; Ozsavci D; Vanizor-Kural B; Yanikkaya-Demirel G; Oba R; Uras F; Demir M
    Clin Appl Thromb Hemost; 2011; 17(6):E79-86. PubMed ID: 21078607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).
    Badrnya S; Assinger A; Volf I
    Int J Mol Sci; 2013 May; 14(5):10107-21. PubMed ID: 23665908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From low-density lipoprotein to platelet activation.
    Akkerman JW
    Int J Biochem Cell Biol; 2008; 40(11):2374-8. PubMed ID: 18468940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory role of lipoprotein oxidation on platelet-vessel wall interactions.
    Bruckdorfer KR
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):493-7. PubMed ID: 9430402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A; Svensson B; Wiebe D; Hoak JC
    Circ Res; 1978 Oct; 43(4):527-34. PubMed ID: 210972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of washed blood platelets in vitro is advanced, accelerated, and enlarged by oxidized low-density lipoprotein.
    Zhao B; Rickert CH; Filler TJ; Liu B; Verhallen PF; Dierichs R
    Am J Hematol; 1995 Jul; 49(3):177-82. PubMed ID: 7604810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.